News
Advertisement
The main themes discussed at DPHARM 2021.
Advertisement
Five therapeutic areas that are apt for an all-virtual approach, and that can serve as an entry point for sponsors who are hesitant yet interested in exploring the growing DCT model.
Advertisement
The latest industry happenings of the last month, all in one place.
Advertisement
Vanessa Tassell, Vice President of Clinical Operations at Mirati Therapeutics, will discuss how some enterprises are navigating trials by incorporating strategies to expand clinical trial access to patients who need it.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
2
ACT Brief: De-Identified Data Expands Trial Design, Global Production Normalizes, and FDA Updates Quality Framework
3
If You Build It ... Will They Come?
4
Where Real-World Evidence Fits Along the Clinical Research Spectrum
5